CNR Institutional Research Information System

OLLA, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.079
NA - Nord America 519
EU - Europa 378
SA - Sud America 102
AF - Africa 13
OC - Oceania 5
Totale 2.096
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 540
US - Stati Uniti d'America 496
IT - Italia 206
CN - Cina 136
VN - Vietnam 94
BR - Brasile 84
HK - Hong Kong 77
ID - Indonesia 49
NL - Olanda 41
FR - Francia 39
TH - Thailandia 35
JP - Giappone 24
IN - India 18
PH - Filippine 18
BD - Bangladesh 17
DE - Germania 17
GB - Regno Unito 17
MY - Malesia 17
FI - Finlandia 16
KR - Corea 15
MX - Messico 9
TR - Turchia 8
AR - Argentina 6
CA - Canada 6
ES - Italia 6
ZA - Sudafrica 6
AT - Austria 5
CO - Colombia 5
IL - Israele 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AU - Australia 4
JM - Giamaica 4
SA - Arabia Saudita 4
IQ - Iraq 3
PL - Polonia 3
UZ - Uzbekistan 3
BE - Belgio 2
CL - Cile 2
GE - Georgia 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
PK - Pakistan 2
RO - Romania 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
UY - Uruguay 2
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MW - Malawi 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
Totale 2.096
Salva come PNG Salva come JPEG
Città #
Singapore 318
Santa Clara 96
San Jose 79
Hong Kong 76
Ashburn 61
Assemini 45
Jakarta 42
Beijing 39
Ho Chi Minh City 38
Bangkok 35
Los Angeles 34
Hefei 30
Lauterbourg 30
Hanoi 23
Tokyo 21
New York 18
Manila 17
Tito 16
Dallas 14
Seoul 14
Cagliari 13
Amsterdam 11
Kuala Selangor 11
Lappeenranta 11
Milan 10
São Paulo 10
Council Bluffs 9
Phoenix 9
Buffalo 8
Florence 8
Brooklyn 7
Houston 7
Rome 7
Kuala Lumpur 6
London 6
Helsinki 5
Johannesburg 5
Monza 5
Stockholm 5
Camporotondo Etneo 4
Frankfurt am Main 4
Haiphong 4
Kingston 4
Mexico City 4
Naples 4
Ankara 3
Bengaluru 3
Boston 3
Can Tho 3
Charlotte 3
Chennai 3
Chicago 3
Dammam 3
Düsseldorf 3
Elk Grove Village 3
Manchester 3
Orem 3
San Gregorio di Catania 3
Surabaya 3
Tashkent 3
Warsaw 3
Acalanes Ridge 2
Assis 2
Atlanta 2
Avellino 2
Bari 2
Belo Horizonte 2
Bologna 2
Brussels 2
Busto Arsizio 2
Camaçari 2
Chaguanas 2
Curitiba 2
Da Nang 2
Denver 2
Dhaka 2
Dongguan 2
Duque de Caxias 2
Feltre 2
Istanbul 2
Lahore 2
Malappuram 2
Medellín 2
Minamishinagawa 2
Montevideo 2
Montreal 2
Mumbai 2
Nairobi 2
Nam Định 2
New Delhi 2
Newark 2
Nha Trang 2
Norderstedt 2
Perugia 2
Pirassununga 2
Poplar 2
Rio de Janeiro 2
Sala Baganza 2
Sydney 2
Tbilisi 2
Totale 1.349
Salva come PNG Salva come JPEG
Nome #
An USH2A founder mutation is the cause of Usher syndrome type 2 in Sardinia 445
COMPOUNDS FOR USE IN PROGRESSIVE MULTIPLE SCLEROSIS 97
Dissection of the BAFF pathway in Multiple Sclerosis with a view toward more specific and effective therapies 89
Complex genetic signatures in immune cells underlie autoimmunity and inform therapy 82
Overexpression of the Cytokine BAFF and Autoimmunity Risk 81
A Sardinian founder mutation in glycoprotein Ib platelet subunit beta(GP1BB) that impacts thrombocytopenia 70
A large-scale screening identified in USH2A gene the P3272L founder pathogenic variant explaining familial Usher syndrome in Sardinia, Italy 68
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies 67
Combining human genetics of multiple sclerosis with oxidative stress phenotype for drug repositioning 64
The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation 63
Rational design of new candidate compounds for multiple sclerosis treatment based on analysis of biological targets identified through genome wide association studies in Sardinia. 58
System and pathway analysis of variants associated with immune cell levels 55
Genetic variants regulating immune cell levels in health and disease. 55
Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS) 49
Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP 49
Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes 49
Biological Potential of Asphodelus microcarpus Extracts: α-Glucosidase and Antibiofilm Activities In Vitro 46
Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes 46
Genetic-Driven Druggable Target Identification and Validation 46
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone 45
Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies 45
Substituted 2-pyrrolinone compounds as inhibitors of B-cell activating factor (BAFF) for autoimmune diseases treatment 41
Rational design and synthesis of edaravone- remyelinating analogues and probes: a preliminary SAR 41
Identification and validation of edaravone remyelinating targets in oligodendrocyte progenitor cells 36
An Alternative QSAR-Based Approach for Predicting the Bioconcentration Factor for Regulatory Purposes 36
OTULIN-related conditions: Report of a new case and review of the literature using GenIA 35
MMsDusty: an Alternative InChI-Based Tool to Minimize Chemical Redundancy 35
Molecular Similarity in Computational Toxicology 34
Pharmacophore modelling: A continuously evolving tool for computational drug design 32
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 31
Phage Display Selection and In Silico Characterization of Peptides as Potential GroEL Modulators 30
Overlapping syndromes in laminopathies: A meta-analysis of the reported literature 29
Anomalous transport and relaxation in classical one-dimensional models 29
An Alternative QSAR-Based Approach for Predicting the Bioconcentration Factor for Regulatory Purposes 27
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors. 26
The Anti-Angiogenic Effect of Cynara cardunculus L. subsp. cardunculus Waste Product 21
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors 21
Drugs Repurposing of Molecules Modulating Human Delta Globin Gene Expression via a Model of Transgenic Foetal Liver Cells: Implications for Beta-Hemoglobinopathy Therapeutics 20
Genetic co-regulation of neopterin and Parkinson’s disease 15
null 12
Totale 2.220
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.850
article - articoli 4.060
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 270
Totale 10.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202418 0 0 0 0 0 0 0 0 2 6 5 5
2024/2025687 1 2 43 20 120 70 59 55 53 33 125 106
2025/20261.515 54 83 295 240 265 89 226 49 49 103 62 0
Totale 2.220